论文部分内容阅读
Programmed death-1 blockade in mismatch repair deficient cancer independent of tumor histology
【作 者】
:
【机 构】
:
Johns Hopkins University,Baltimore,MD The Sidney
【出 处】
:
2016年临床肿瘤学新进展学术研讨会
【发表日期】
:
2016年5期
其他文献
Pembrolizumab versus ipilimumab for advanced melanoma:Final overall survival analysis of KEYNOTE-006
会议
Genomic analysis and 3-y efficacy and safety update of COMBI-d:A phase 3 study of dabrafenib(D)+tram
会议
A phase Ⅰb dose escalation trial of isatuximab(SAR650984,anti-CD38 mAb)plus lenalidomide and dexamet
会议
Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participantsin SWOG clini
会议
Benefits of physician orders for scope of treatment(POST)forms on end-of-life care incancer patients
会议
A URCC NCORP nationwide randomized controlled trial investigating the effect of exercise on chemothe
会议
Placebo-controlled phase Ⅲ study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor an
会议